Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
about
Mycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammationRevisiting Crohn's disease as a primary immunodeficiency of macrophagesRecent Insights Into the Genetics of Inflammatory Bowel DiseaseNOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophagesBacterial outer membrane vesicles and vaccine applicationsRole of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisInnate immune gene polymorphisms in tuberculosisThe cooperation between the autophagy machinery and the inflammasome to implement an appropriate innate immune response: do they regulate each other?International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and diseaseMuramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infectionInflammatory bowel diseaseThe Broad Street pump revisited: dairy farms and an ongoing outbreak of inflammatory bowel disease in Forest, VirginiaInteractions between the host innate immune system and microbes in inflammatory bowel disease.Crohn's disease: NOD2, autophagy and ER stress converge.Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin MincleRegulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptorsCell-autonomous effector mechanisms against mycobacterium tuberculosis.The cell envelope glycoconjugates of Mycobacterium tuberculosisLeprosy and the human genomeModifications to the peptidoglycan backbone help bacteria to establish infectionp62/SQSTM1 enhances NOD2-mediated signaling and cytokine production through stabilizing NOD2 oligomerization.Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection.Macrophage immunoregulatory pathways in tuberculosis.Comparative genomics for mycobacterial peptidoglycan remodelling enzymes reveals extensive genetic multiplicityThe biology of bacterial peptidoglycans and their impact on host immunity and physiology.Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice.IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and NO production in human macrophages.Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.Messenger functions of the bacterial cell wall-derived muropeptides.Structural characterization of muropeptides from Chlamydia trachomatis peptidoglycan by mass spectrometry resolves "chlamydial anomaly".Activity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell DeathIn vitro immunomodulation of a whole blood IFN-γ release assay enhances T cell responses in subjects with latent tuberculosis infection.Signaling through NOD-2 and TLR-4 Bolsters the T cell Priming Capability of Dendritic cells by Inducing Autophagy.Autophagy-Related Proteins Target Ubiquitin-Free Mycobacterial Compartment to Promote Killing in MacrophagesPeptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2Triggering through NOD-2 Differentiates Bone Marrow Precursors to Dendritic Cells with Potent Bactericidal activity.Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β.NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease.Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.
P2860
Q22241484-6785B083-149E-4CC7-8226-D843A6CE18A3Q22242983-216D4484-5D58-42F1-8BC6-02D3EFE57C11Q22250935-474FD382-AC3D-4C62-B992-44C89AA6EC49Q24305119-F0518FF6-59B1-4E1D-9A1D-46B49598087AQ24568229-8C536912-11E0-4F89-91F9-67E72C4D6332Q26777991-214DAC47-03B8-4016-901F-4D9A7C3B38ABQ27000486-319C18BB-9C9C-4983-8451-C31F24959233Q27026138-C08DB60A-F25B-465C-9214-D06AFC920465Q28081406-4E69C858-1EB5-42A6-B99B-330BBDCDB9C9Q28483612-00036BFA-95EE-49FC-BCA7-BFEAD77C0519Q29615500-C4C8DAFF-D2A1-4163-AD61-AC8A1EA8CAA0Q30428221-432A1858-2505-4382-8B8B-6891188E2496Q33554402-6E91C3F5-8034-491A-9BE7-4F0CB7EBE774Q34025428-64CB0BBC-64FB-4D97-A349-2B0250F1A469Q34087974-509DED02-CFBA-4B2E-9A49-F9247A8241C1Q34104329-A4AC6627-482D-42B0-B08F-BDAA8455D52AQ34287676-F4E89D4A-39AD-4F36-BFD9-DF2223923B08Q34423962-0352FB24-D7EF-4166-8407-B1A6971C5AADQ34431856-BF2BD3F0-72AC-452E-8C9F-78C5659C827AQ34529521-435074B9-45A6-4034-8F18-5D2889CEB9EBQ34600136-66C1BA19-2843-4AC6-B90D-AAD18506A817Q34769278-511A8722-308F-4B70-BBF3-3D8A319E7E8BQ35039679-BD65F0C4-4DF2-4965-87D8-2E1A56E7DE5FQ35128909-F9E1D031-867B-4ECA-A561-FD32AD8597B5Q35159329-700A4838-AC83-4439-875C-32C84803BD71Q35187119-D3565C4B-E402-486A-808C-595CD5486E3CQ35551021-C973652B-6303-4CE0-AEF5-43AA369BF4E5Q35627704-36076AD1-274D-4EC6-956D-07FC40D0D3E7Q35933419-128AC996-C4B2-45F8-8D84-F8DFC9B3BE15Q35936721-E74352E4-BEC6-4041-8CFA-923F0111454CQ36079175-4038B77F-65D2-49B2-AC25-E8122455D639Q36162984-5337E9FF-3AD1-4DB4-B33F-F0700EA9CA41Q36353973-7AF70B99-D1DF-440B-8892-7E9948676DC1Q36453366-10C93B4B-B4CB-4A68-95CE-B8E739DD2D7AQ36889667-3F16E05E-FB98-41CA-88A1-65BF431C13F6Q36930037-9DE3A939-48C3-4670-A95E-D6FE052AB352Q36970544-1F11736F-3DB8-424E-9626-DE092EA9A705Q37040409-524321C7-D61E-43E3-893E-33192D5B5C8DQ37172148-D4AB636E-0584-4B22-9AED-A564313D8036Q37199844-3E1952A1-3007-49C3-B414-89E16DBC0D1F
P2860
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
@en
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
@nl
type
label
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
@en
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
@nl
prefLabel
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
@en
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
@nl
P2093
P2860
P356
P1476
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
@en
P2093
Amit K Pandey
Christopher M Sassetti
François Coulombe
Frédéric Veyrier
James L Gleason
Louis de Léséleuc
Marcel A Behr
Maziar Divangahi
Michael B Reed
Michelle A Kelliher
P2860
P304
P356
10.1084/JEM.20081779
P407
P577
2009-07-06T00:00:00Z